AXSM:US
$103.755
-0.846%
Axsome Therapeutics Inc.Insider Activity
Last updated: May 30, 2025, 11:00 AM ET
Profile
Company Description
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14.